Dogecoin Cash, Inc. Name Change Finalized and Reflected on U.S. Markets Following FINRA Notification

Company Overview - Dogecoin Cash, Inc. has finalized its corporate name change, which is now reflected across U.S. stock market systems following notification from FINRA [1] - The name change was authorized through a Certificate of Amendment filed with the Nevada Secretary of State on November 13, 2024, and became market effective on April 25, 2025 [2] - The trading symbol (CBDS) remains unchanged at this time [3] Business Operations - Dogecoin Cash, Inc. operates PrestoDoctor, a leader in medical cannabis telemedicine [4] - The company holds the first patented cannabis strain, Ecuadorian Sativa aka "CTA", and a patented cannabis lozenge for hypertension treatment [4] - Dogecoin Cash, Inc. is engaged in cannabis product development, licensing, and blockchain innovation, leveraging emerging digital assets and decentralized finance (DeFi) solutions [4]